Stifel Financial Corp Sells 7,560 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Stifel Financial Corp lessened its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 27.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,079 shares of the health services provider’s stock after selling 7,560 shares during the period. Stifel Financial Corp’s holdings in Teladoc Health were worth $184,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in TDOC. Point72 Asset Management L.P. raised its stake in shares of Teladoc Health by 57.8% in the third quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock worth $76,803,000 after purchasing an additional 3,063,172 shares during the last quarter. Rubric Capital Management LP purchased a new position in shares of Teladoc Health during the second quarter valued at approximately $45,267,000. Clearline Capital LP grew its holdings in Teladoc Health by 395.6% during the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock worth $42,682,000 after buying an additional 3,483,665 shares in the last quarter. Assenagon Asset Management S.A. purchased a new stake in Teladoc Health in the 3rd quarter valued at $15,801,000. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its stake in Teladoc Health by 15.5% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider’s stock valued at $15,617,000 after acquiring an additional 228,004 shares in the last quarter. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Trading Down 1.5 %

Shares of Teladoc Health stock opened at $9.31 on Tuesday. The company’s 50-day moving average price is $9.84 and its 200-day moving average price is $9.06. The company has a market cap of $1.60 billion, a price-to-earnings ratio of -1.61 and a beta of 0.97. Teladoc Health, Inc. has a 12-month low of $6.76 and a 12-month high of $22.54. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.10. The business had revenue of $640.51 million for the quarter, compared to analysts’ expectations of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. On average, equities analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Insider Activity at Teladoc Health

In related news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the transaction, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. This represents a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.95% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

TDOC has been the subject of several recent analyst reports. Barclays upped their target price on shares of Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Deutsche Bank Aktiengesellschaft upped their target price on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday, November 1st. TD Cowen dropped their price target on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Thursday, October 31st. Jefferies Financial Group raised their target price on Teladoc Health from $8.00 to $10.00 and gave the company a “hold” rating in a research report on Tuesday, September 17th. Finally, Royal Bank of Canada boosted their price target on shares of Teladoc Health from $9.00 to $10.00 and gave the stock an “outperform” rating in a report on Wednesday, October 9th. Fourteen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, Teladoc Health has an average rating of “Hold” and an average price target of $12.24.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.